These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34286856)

  • 1. Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study.
    Blain H; Tuaillon E; Gamon L; Pisoni A; Miot S; Rolland Y; Picot MC; Bousquet J
    Allergy; 2022 Jan; 77(1):271-281. PubMed ID: 34286856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong Decay of SARS-CoV-2 Spike Antibodies after 2 BNT162b2 Vaccine Doses and High Antibody Response to a Third Dose in Nursing Home Residents.
    Blain H; Tuaillon E; Gamon L; Pisoni A; Miot S; Picot MC
    J Am Med Dir Assoc; 2022 May; 23(5):750-753. PubMed ID: 35311651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor binding domain-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks.
    Blain H; Tuaillon E; Gamon L; Pisoni A; Miot S; Delpui V; Si-Mohamed N; Niel C; Rolland Y; Montes B; Groc S; Rafasse S; Dupuy AM; Gros N; Muriaux D; Picot MC; Bousquet J
    Allergy; 2022 Jun; 77(6):1885-1894. PubMed ID: 34652831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents.
    Tuaillon E; Pisoni A; Veyrenche N; Rafasse S; Niel C; Gros N; Muriaux D; Picot MC; Aouinti S; Van de Perre P; Bousquet J; Blain H
    Sci Rep; 2022 Aug; 12(1):13749. PubMed ID: 35962053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.
    Chong Y; Goto T; Tani N; Yonekawa A; Ikematsu H; Shimono N; Tanaka Y; Akashi K
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1066-1071. PubMed ID: 35962568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.
    Schiavoni I; Palmieri A; Olivetta E; Leone P; Di Lonardo A; Mazzoli A; Cafariello C; Malara A; Palamara AT; Incalzi RA; Onder G; Stefanelli P; Fedele G;
    J Am Med Dir Assoc; 2023 Feb; 24(2):140-147.e2. PubMed ID: 36587928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.
    Montoya JG; Adams AE; Bonetti V; Deng S; Link NA; Pertsch S; Olson K; Li M; Dillon EC; Frosch DL
    Microbiol Spectr; 2021 Dec; 9(3):e0116221. PubMed ID: 34756093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-spike IgG antibody kinetics following the second and third doses of BNT162b2 vaccine in nursing home residents.
    Jeulin H; Labat C; Duarte K; Toupance S; Nadin G; Craus D; Georgiopoulos I; Gantois I; Goehringer F; Benetos A
    J Am Geriatr Soc; 2022 Sep; 70(9):2552-2560. PubMed ID: 35484977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immunity induced by mRNA COVID-19 vaccines in Nursing Home Residents previously infected with SARS-CoV-2.
    Fedele G; Palmieri A; Damiano C; Di Lonardo A; Leone P; Schiavoni I; Trevisan C; Abbatecola AM; Cafariello C; Malara A; Minchella P; Panduri G; Antonelli Incalzi R; Palamara AT; Stefanelli P; Onder G;
    Aging Clin Exp Res; 2022 Oct; 34(10):2577-2584. PubMed ID: 36127623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
    Casas Fischer R
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
    Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
    JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgG.
    Katz MJ; Heaney CD; Pisanic N; Smith L; Bigelow BF; Sheikh F; Boudreau A; Kruczynski K; Hsu YJ; Salinas AB; Cosgrove SE; Rock C
    J Am Geriatr Soc; 2022 Mar; 70(3):659-668. PubMed ID: 35038344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response kinetics to SARS-CoV-2 infection and COVID-19 vaccination among nursing home residents-Georgia, October 2020-July 2022.
    Chisty ZA; Li DD; Haile M; Houston H; DaSilva J; Overton R; Schuh AJ; Haynie J; Clemente J; Branch AG; Arons MM; Tsang CA; Pellegrini GJ; Bugrysheva J; Ilutsik J; Mohelsky R; Comer P; Hundia SB; Oh H; Stuckey MJ; Bohannon CD; Rasheed MAU; Epperson M; Thornburg NJ; McDonald LC; Brown AC; Kutty PK
    PLoS One; 2024; 19(4):e0301367. PubMed ID: 38625908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of antibody titers after two doses of mRNA Pfizer-BioNTech vaccine and effect of the third dose in nursing home residents.
    Rodríguez-Avial I; García-Salguero C; Bermejo L; Teja J; Pérez-Cecilia E; Delgado-Iribarren A; Vigara M; Gil P; Culebras E
    PLoS One; 2023; 18(3):e0282388. PubMed ID: 36888608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status.
    Helle F; Moyet J; Demey B; François C; Duverlie G; Castelain S; Bloch F; Brochot E
    Vaccine; 2022 Jan; 40(3):531-535. PubMed ID: 34893341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals.
    Hayer J; Urlaub E
    Microbiol Spectr; 2022 Jun; 10(3):e0270921. PubMed ID: 35575594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities.
    Trigueros M; Pradenas E; Palacín D; Muñoz-López F; Ávila-Nieto C; Trinité B; Bonet-Simó JM; Isnard M; Moreno N; Marfil S; Rovirosa C; Puig T; Grau E; Chamorro A; Martinez A; Toledo R; Font M; Ara J; Carrillo J; Mateu L; Blanco J; Clotet B; Prat N; Massanella M;
    Age Ageing; 2022 May; 51(5):. PubMed ID: 35595256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.